Epigral Limited (BOM:543332)
India · Delayed Price · Currency is INR 1,128.00
-12.95 (-1.14%)
At close: Jun 19, 2026
Epigral Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 25,272 | 25,501 | 19,292 | 21,884 | 15,509 | |
Revenue Growth (YoY) | -0.90% | 32.19% | -11.85% | 41.10% | 87.18% |
Cost of Revenue | 15,748 | 14,760 | 11,590 | 12,275 | 8,452 |
Gross Profit | 9,524 | 10,742 | 7,702 | 9,609 | 7,058 |
Selling, General & Admin | 1,364 | 1,275 | 1,019 | 885.53 | 768.3 |
Other Operating Expenses | 2,478 | 2,359 | 1,864 | 1,809 | 1,193 |
Operating Expenses | 5,526 | 4,960 | 4,118 | 3,784 | 2,820 |
Operating Income | 3,998 | 5,782 | 3,583 | 5,825 | 4,238 |
Interest Expense | -466.5 | -461.2 | -734 | -661.75 | -473 |
Interest & Investment Income | 8.8 | 3.3 | 1 | 8.43 | 1.59 |
Earnings From Equity Investments | -10.4 | 9.9 | 0.3 | -0.17 | - |
Currency Exchange Gain (Loss) | -2.5 | 72.5 | 88.5 | 30.05 | 53.47 |
Other Non Operating Income (Expenses) | -214.2 | -65 | -31.1 | 13.71 | -2.1 |
EBT Excluding Unusual Items | 3,314 | 5,342 | 2,908 | 5,215 | 3,818 |
Gain (Loss) on Sale of Investments | 26.5 | 18.9 | - | - | - |
Gain (Loss) on Sale of Assets | 65.5 | 50.4 | -0.5 | -0.05 | -0.72 |
Pretax Income | 3,408 | 5,411 | 2,908 | 5,225 | 3,834 |
Income Tax Expense | 87.9 | 1,834 | 948.8 | 1,692 | 1,306 |
Net Income | 3,320 | 3,577 | 1,959 | 3,533 | 2,528 |
Net Income to Common | 3,320 | 3,577 | 1,959 | 3,533 | 2,528 |
Net Income Growth | -7.19% | 82.62% | -44.56% | 39.76% | 150.68% |
Shares Outstanding (Basic) | 43 | 42 | 42 | 42 | 42 |
Shares Outstanding (Diluted) | 43 | 42 | 42 | 42 | 42 |
Shares Change (YoY) | 2.14% | 1.66% | - | - | -28.88% |
EPS (Basic) | 76.95 | 84.68 | 47.14 | 85.03 | 60.84 |
EPS (Diluted) | 76.95 | 84.68 | 47.14 | 85.03 | 60.84 |
EPS Growth | -9.13% | 79.64% | -44.56% | 39.76% | 252.48% |
Free Cash Flow | 413.8 | 2,459 | -8 | 2,097 | -1,725 |
Free Cash Flow Per Share | 9.59 | 58.21 | -0.19 | 50.47 | -41.51 |
Dividend Per Share | 5.000 | 6.000 | 5.000 | 5.000 | - |
Dividend Growth | -16.67% | 20.00% | - | - | - |
Gross Margin | 37.69% | 42.12% | 39.92% | 43.91% | 45.51% |
Operating Margin | 15.82% | 22.67% | 18.57% | 26.62% | 27.32% |
Profit Margin | 13.14% | 14.03% | 10.15% | 16.14% | 16.30% |
Free Cash Flow Margin | 1.64% | 9.64% | -0.04% | 9.58% | -11.12% |
EBITDA | 5,598 | 7,065 | 4,785 | 6,891 | 5,084 |
EBITDA Margin | 22.15% | 27.70% | 24.80% | 31.49% | 32.78% |
D&A For EBITDA | 1,600 | 1,283 | 1,202 | 1,066 | 846.62 |
EBIT | 3,998 | 5,782 | 3,583 | 5,825 | 4,238 |
EBIT Margin | 15.82% | 22.67% | 18.57% | 26.62% | 27.32% |
Effective Tax Rate | 2.58% | 33.89% | 32.63% | 32.38% | 34.07% |
Revenue as Reported | 25,422 | 25,653 | 19,358 | 21,964 | 15,551 |